GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the pricing of its underwritten public offering of 2,560,000 units at a price to the public of $5.00 per unit. Each unit issued in the offering consists of one share of…

Read More

By: Claire Jarvis, PhD Healthcare providers, industry, elected officials, and patient advocates came together virtually September 22nd for Georgia Bio’s inaugural Patient Advocacy Summit. The ongoing COVID-19 pandemic has highlighted long-standing public health disparities that result in an inequitable healthcare experience across the patient community. The summit’s speakers argued that these disparities will only be…

Read More

The amount of funding each jurisdiction receives will be based on its population size. The Centers for Disease Control and Prevention is distributing $200 million to help jurisdictions prepare for the COVID-19 vaccine, the Department of Health and Human Services announced Wednesday. The money will be sent through CDC’s existing immunization cooperative agreement and will help support 64 jurisdictions…

Read More

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both accepted marketing application submissions for UCB’s psoriasis treatment bimekizumab. UCB is seeking approval for bimekizumab in both the US and EU for the treatment of moderate-to-severe plaque psoriasis in adults. Both marketing applications are based on a data package from UCB’s…

Read More

Siemens Healthineers has inked what it describes as a “master collaboration agreement” with Novartis to help provide diagnostic tests linked to therapies across the drugmaker’s pipeline. To start, the companies will design and develop a biomarker test aimed at neuroscience programs, and multiple sclerosis specifically—a treatment area that they expect to expand into a $23.5…

Read More

The National Institutes of Health has picked seven companies and academic centers to help develop digital health solutions aimed at the COVID-19 pandemic—including smartphone apps, wearables and big data programs to mitigate the personal and public health impacts of the novel coronavirus. Each one-year contract includes two phases: an initial award for feasibility testing, followed…

Read More

Answers to more than 80,000health questions from Sharecare integrated into Amazon’s cloud-based voice service Sharecare, the digital health company that helps people manage all their health in one place through its comprehensive and data-driven virtual heath platform, today announced it is integrating its library of more than 80,000 questions and answers on various health and…

Read More

Biogen invests $250 million in a 20-year initiative to accelerate action on the greatest challenges of our time: climate, health and equity. Fossil fuel-related air pollution not only contributes to the climate crisis, it claims 9 million lives annually, making it one the world’s top killers1. Evidence shows that fossil fuel emissions play a direct role…

Read More

100-million-plus antigen tests to be shipped by end of fall The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data from the association’s COVID-19 testing supply registry. “COVID-19 testing is one of the main components of our…

Read More

In this era of the COVID-19 pandemic, the best way to avoid a double whammy this fall is to get a flu shot. Two of Georgia’s leading vaccine scientists were guest speakers at Thursday’s quarterly meeting of the Georgia Research Alliance, the influential public-private entity charged with forming ties between the state, business and academia.…

Read More